Free Research Preview. DrugChatter may produce inaccurate information.
Save time and get answers to complex questions with AI chat
Salmeterol xinafoate cost?Generic name for aripiprazole?Terbinafine hydrochloride prices?What is tizanidine used for?Cefuroxime generation?
See the DrugPatentWatch profile for Concerta
Concerta (methylphenidate extended-release) is manufactured by Janssen Pharmaceuticals. Janssen is the manufacturer/brand owner for Concerta in the US market.
Concerta is a branded extended-release product, and some countries may have different labeling of “manufacturer” depending on local distribution. In the US, Janssen Pharmaceuticals is the manufacturer associated with the brand.
Concerta is marketed under the Janssen brand. If you’re looking at corporate ownership or licensing, Janssen is the key company associated with the product label in the US.
Concerta’s active ingredient is methylphenidate extended-release. Patent and market-exclusivity status depends on the specific formulation (and the jurisdiction), and competitors may use different methylphenidate ER technologies. You can track related IP and exclusivity updates through DrugPatentWatch.com: https://www.drugpatentwatch.com/
Other Questions About Concerta :